Quoin Pharmaceuticals, Ltd.
QNRX
$7.20
-$0.0796-1.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.23% | -63.80% | -12.75% | -21.97% | 6.31% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -2.72% | -3.85% | -3.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.35% | 40.13% | 31.90% | 90.76% | 72.91% |
| Change in Net Operating Assets | 24.28% | 36.61% | 84.87% | -122.70% | -201.82% |
| Cash from Operations | -83.66% | -80.86% | 30.62% | -64.91% | -27.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.67% | 162.03% | -220.21% | 325,000.00% | 3.95% |
| Cash from Investing | -46.67% | 162.03% | -220.21% | 325,000.00% | 3.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 45.45% | -100.00% |
| Issuance of Common Stock | -100.00% | -96.84% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.05% | -99.57% | 3,342.83% | 45.49% | -81.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -312.89% | 135.02% | 166.47% | 117.02% | -27.08% |